Jun 07, 2023 / 08:00PM GMT
Roger Song - Jefferies - Analyst
Welcome, everyone. And our next presenting company is GlycoMimetics. And I welcome CEO, Harout Semerjian. How are you?
Harout Semerjian - GlycoMimetics, Inc. - President & CEO
I'm very good. Thank you.
Questions and Answers:
Roger Song - Jefferies - AnalystAwesome. Yeah. Maybe before we talk about your exciting program and the upcoming catalysts, just for the people who maybe already know GlycoMimetics, but maybe some of them are new to the story, what's your updated elevator pitch for investors?
Harout Semerjian - GlycoMimetics, Inc. - President & CEO
Thank you, Roger. GlycoMimetics is a clinical-stage company, actually a late-clinical stage company at this point, really focusing on debilitating diseases such as oncology, hematology, inflammatory diseases. We have a proprietary platform dealing with carbohydrates and glycobiology, which we believe is a very exciting area. And now more and more, we're starting to bring some of